|
US20020137890A1
(en)
*
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20060160181A1
(en)
*
|
2000-02-15 |
2006-07-20 |
Amgen Inc. |
Fibroblast Growth Factor-23 molecules and uses thereof
|
|
AU2001249125A1
(en)
*
|
2000-03-08 |
2001-09-17 |
Chiron Corporation |
Human fgf-23 gene and gene expression products
|
|
KR100886276B1
(ko)
*
|
2000-08-11 |
2009-03-04 |
기린 파마 가부시끼가이샤 |
인산 대사, 칼슘 대사, 석회화 및 비타민 ｄ 대사를조절하는 폴리펩티드 및 그것을 코딩하는 ｄｎａ
|
|
US7226749B2
(en)
|
2000-12-05 |
2007-06-05 |
Zahradnik Richard J |
Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
|
|
US6838264B2
(en)
|
2000-12-05 |
2005-01-04 |
Immutopics, Inc. |
Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
|
|
JPWO2002052009A1
(ja)
*
|
2000-12-26 |
2004-04-30 |
中外製薬株式会社 |
血中リン濃度を低下させるヒトｆｇｆ２３タンパク質変異体
|
|
CA2443719A1
(en)
*
|
2001-04-26 |
2002-11-07 |
Geneprot, Inc. |
Human fibroblast growth factor-related compositions
|
|
DE60329070D1
(de)
*
|
2001-12-28 |
2009-10-15 |
Kyowa Hakko Kirin Co Ltd |
Antikörper gegen den fibroblastenwachstumsfaktor 23
|
|
US7094551B2
(en)
|
2002-09-17 |
2006-08-22 |
Zahradnik Richard J |
Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23
|
|
WO2005045044A2
(en)
*
|
2003-11-07 |
2005-05-19 |
Novartis Ag |
Use of fibroblast growth factor fragments
|
|
IL161886A0
(en)
*
|
2004-05-09 |
2005-11-20 |
Technion Res & Dev Foundation |
Development of inducers of udp-n-acetyl-alphad-galactosamine: polypeptide n-acetylgalactosami-nyltransferase 3(ppgantase
|
|
WO2005108607A1
(en)
*
|
2004-05-09 |
2005-11-17 |
Technion Research & Development Foundation Ltd. |
Compositions and methods for treating disorders associated with abnormal phosphate metabolism
|
|
US20060236220A1
(en)
*
|
2005-04-18 |
2006-10-19 |
Clearplay, Inc. |
Apparatus, System and Method for Associating One or More Filter Files with a Particular Multimedia Presentation
|
|
KR100760525B1
(ko)
*
|
2006-04-13 |
2007-10-04 |
김재만 |
병원성 미생물의 무증폭 다중 정량 검출킷트 및 검출방법
|
|
US8012694B2
(en)
|
2006-09-14 |
2011-09-06 |
Immutopics, Inc. |
Assay for the detection of phosphorylated PTH
|
|
US8058015B2
(en)
|
2007-01-22 |
2011-11-15 |
Medizinische Universität Innsbruck |
Markers for chronic kidney disease
|
|
US7883705B2
(en)
|
2007-02-14 |
2011-02-08 |
Kyowa Hakko Kirin Co., Ltd. |
Anti FGF23 antibody and a pharmaceutical composition comprising the same
|
|
US20110183434A1
(en)
*
|
2008-01-17 |
2011-07-28 |
Myles Wolf |
Diagnostic methods and kits using fibroblast growth factor-23
|
|
US8420088B2
(en)
|
2008-01-28 |
2013-04-16 |
Novartis Ag |
Methods and compositions using FGF23 fusion polypeptides
|
|
TW200936156A
(en)
|
2008-01-28 |
2009-09-01 |
Novartis Ag |
Methods and compositions using Klotho-FGF fusion polypeptides
|
|
CA2720888A1
(en)
*
|
2008-04-29 |
2009-11-05 |
Novartis Ag |
Methods of monitoring the modulation of the kinase activity of fibroblast growth factor receptor and uses of said methods
|
|
US8889621B2
(en)
*
|
2009-10-30 |
2014-11-18 |
New York University |
Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of hypophosphatemia
|
|
US20110195077A1
(en)
|
2010-01-29 |
2011-08-11 |
Novartis Ag |
Methods and compositions using fgf23 fusion ppolypeptides
|
|
KR101882533B1
(ko)
|
2010-08-31 |
2018-07-26 |
교와 메덱스 가부시키가이샤 |
섬유아세포 증식 인자-２３ 의 측정 방법 및 측정 시약
|
|
WO2012055096A1
(zh)
*
|
2010-10-27 |
2012-05-03 |
温州医学院生物与天然药物开发中心有限公司 |
抗fgf-23抗体的制备方法及用途
|
|
WO2012177481A2
(en)
|
2011-06-24 |
2012-12-27 |
University Of Miami |
Fibroblast growth factor receptor inhibition for the treatment of disease
|
|
WO2013006486A2
(en)
|
2011-07-01 |
2013-01-10 |
Ngm Biopharmaceuticals, Inc. |
Compositions, uses and methods for treatment of metabolic disorders and diseases
|
|
WO2013027191A1
(en)
|
2011-08-25 |
2013-02-28 |
Novartis Ag |
Methods and compositions using fgf23 fusion polypeptides
|
|
US9657075B2
(en)
|
2012-06-07 |
2017-05-23 |
New York University |
Chimeric fibroblast growth factor 23 proteins and methods of use
|
|
US9290557B2
(en)
|
2012-11-28 |
2016-03-22 |
Ngm Biopharmaceuticals, Inc. |
Compositions comprising variants and fusions of FGF19 polypeptides
|
|
HK1214832A1
(zh)
|
2012-11-28 |
2016-08-05 |
恩格姆生物制药公司 |
用於代謝病症和疾病治療的組合物和方法
|
|
MX383664B
(es)
|
2012-12-27 |
2025-03-14 |
Ngm Biopharmaceuticals Inc |
Uso de un péptido para modular la homeostasis de los ácidos biliares o tratamiento de una enfermedad relacionada con los ácidos biliares.
|
|
US9273107B2
(en)
|
2012-12-27 |
2016-03-01 |
Ngm Biopharmaceuticals, Inc. |
Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
|
|
US9550820B2
(en)
|
2013-02-22 |
2017-01-24 |
New York University |
Chimeric fibroblast growth factor 23/fibroblast growth factor 19 proteins and methods of use
|
|
US10745668B2
(en)
*
|
2013-09-20 |
2020-08-18 |
Lonza Ltd |
Methods for nuclear reprogramming of cells
|
|
WO2015065897A1
(en)
|
2013-10-28 |
2015-05-07 |
Ngm Biopharmaceuticals, Inc. |
Cancer models and associated methods
|
|
PT3097122T
(pt)
|
2014-01-24 |
2020-07-21 |
Ngm Biopharmaceuticals Inc |
Anticorpos de ligação de domínio 2 de beta klotho e métodos de utilização dos mesmos
|
|
AU2015237176A1
(en)
|
2014-03-28 |
2016-10-20 |
New York University |
FGF23 fusion proteins
|
|
US10398758B2
(en)
|
2014-05-28 |
2019-09-03 |
Ngm Biopharmaceuticals, Inc. |
Compositions comprising variants of FGF19 polypeptides and uses thereof for the treatment of hyperglycemic conditions
|
|
PE20170248A1
(es)
*
|
2014-06-09 |
2017-04-14 |
Ultragenyx Pharmaceutical Inc |
El control efectivo y eficaz del fosfato serico para una osificacion optima
|
|
WO2015195509A2
(en)
|
2014-06-16 |
2015-12-23 |
Ngm Biopharmaceuticals, Inc. |
Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
|
|
CN114129709A
(zh)
|
2014-10-23 |
2022-03-04 |
恩格姆生物制药公司 |
包含肽变异体的药物组合物及其使用方法
|
|
US10434144B2
(en)
|
2014-11-07 |
2019-10-08 |
Ngm Biopharmaceuticals, Inc. |
Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders
|
|
CN107810201A
(zh)
|
2014-12-04 |
2018-03-16 |
诺华股份有限公司 |
使用klotho变体多肽的方法和组合物
|
|
CN105699664A
(zh)
*
|
2015-04-13 |
2016-06-22 |
陈柏龄 |
Fgf23检测试剂盒及其制备方法
|
|
EP3313996A1
(en)
*
|
2015-06-25 |
2018-05-02 |
Amyris, Inc. |
Maltose dependent degrons, maltose-responsive promoters, stabilization constructs, and their use in production of non-catabolic compounds
|
|
WO2017019957A2
(en)
|
2015-07-29 |
2017-02-02 |
Ngm Biopharmaceuticals, Inc. |
Binding proteins and methods of use thereof
|
|
JP6728352B2
(ja)
|
2015-11-09 |
2020-07-22 |
エヌジーエム バイオファーマシューティカルス，インコーポレーテッド |
胆汁酸に関係した障害の治療方法
|
|
EP3503882A4
(en)
|
2016-08-26 |
2020-07-29 |
NGM Biopharmaceuticals, Inc. |
METHOD FOR TREATING FIBROBLAST GROWTH FACTOR-19-MEDIATED CARCINOMAS AND TUMORS
|
|
CA3058306A1
(en)
*
|
2017-03-28 |
2018-10-04 |
Ajinomoto Co., Inc. |
Additive for undifferentiation maintaining medium
|
|
WO2018221544A1
(ja)
|
2017-05-31 |
2018-12-06 |
協和メデックス株式会社 |
線維芽細胞増殖因子－２３の測定方法、測定試薬及び測定キット
|
|
WO2020047475A1
(en)
*
|
2018-08-30 |
2020-03-05 |
The Uab Research Foundation |
Drug screening for fgf23-fgfr4 inhibitors
|
|
KR20220029546A
(ko)
*
|
2019-03-29 |
2022-03-08 |
아타르가, 엘엘씨 |
항 fgf23 항체
|
|
BR112021020888A2
(pt)
*
|
2019-04-19 |
2021-12-21 |
Genethon |
Terapia gênica de doenças hipofosfatêmicas relacionadas a fator de crescimento fibroblástico 23
|